Benzinga

APRIL 13, 2022

GlaxoSmithKline plc (NYSE: GSK ) has agreed to acquire Sierra Oncology Inc (NASDAQ: SRRA ) for $55 per share in cash, representing an approximate total equity value of $1.9 billion (£1.5 Sierra's momelotinib complements GSK's Blenrep (belantamab mafodotin), building on GSK's commercial and medical expertise in hematology.

Equity 98

Equity 98

Benzinga

JUNE 1, 2022

Close on the heels of an M&A deal , GlaxoSmithKline plc (NYSE: GSK ) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. What Happened: GSK said it is spinning off its consumer healthcare business into an independently-traded public company, named Haleon, a regulatory filing on Wednesday showed.

Dividends 98

Dividends 98

Benzinga

SEPTEMBER 15, 2022

Fortune Business Insights™, provide this information in its latest report titled, "Medical Imaging Market Forecast, 2019-2027.". The major oncology drugs market players are AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, and Medtronic plc. Pune, India, Sept.

Marketability 40

Marketability 40

Benzinga

SEPTEMBER 13, 2022

This information is cited by Fortune Business Insights™ in its research report titled, Influenza Vaccine Market, 2022-2029. GlaxoSmithKline plc (U.K.), Key Industry Development: January 2021 – ModernaTX, Inc. Market Size in 2021. Historical Data for. 2018 to 2020. Key Players Covered in Influenza Vaccine Market. Growth Drivers.

Marketability 40

Marketability Technology 40

Benzinga

SEPTEMBER 6, 2022

Fortune Business Insights™ has presented this information in its report titled "Dietary Supplements Market, 2021-2028". GlaxoSmithKline plc (Brentford, U.K.). Pune, India, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The global dietary supplements market size is anticipated to hit USD 128.64 The market size stood at USD 61.20 Pfizer Inc.

Marketability 40

Marketability 40

Benzinga

JUNE 22, 2022

This information is published by Fortune Business Insights™ in its report titled, "Monoclonal Antibody Therapy Market, 2021-2028.". April 2020: GlaxoSmithKline plc and Vir Biotechnology, Inc. The market is projected to grow from USD 178.50 billion in 2021 to USD 451.89 billion in 2028 at a CAGR of 14.1% in the 2021-2028 period.

Marketability 40

Marketability Technology 40

Benzinga

MAY 18, 2022

Fortune Business Insights ™ presents this information in its report titled " Nicotine Gum Market, 2022-2029.". GlaxoSmithKline plc (U.K.). The market is expected to reach USD 2.17 billion by 2029, exhibiting a CAGR of 4.8% during the forecast period. COVID-19 Pandemic. Manufacturing Restrictions to Impede Market Progress.

Marketability 40

Marketability 40